Back to Journals » Drug Design, Development and Therapy » Volume 9

Current and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents

Total article views   HTML views PDF downloads Totals
22,560 Dovepress* 17,535+ 2,252 19,787
PubMed Central* 5,025 1,588 6,613
Totals 22,560 3,840 26,400
*Since 7 January 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 1 3

View citations on PubMed Central and Google Scholar